EURONEXT NV/ NL0006294274 /
2024-06-03 9:05:31 AM | Chg. +1.45 | Volume | Bid5:30:06 PM | Ask5:30:06 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
89.85EUR | +1.64% | 0 Turnover: - |
-Bid Size: - | -Ask Size: - | 9.64 bill.EUR | 2.76% | 18.60 |
GlobeNewswire
6:15 PM
Acticor Biotech updates its glenzocimab clinical development plan for the treatment of cardiovascula...
GlobeNewswire
5:35 PM
Valneva Announces Publication of Lyme Disease Phase 2 Trials in the Lancet Infectious Diseases
GlobeNewswire
7:30 AM
Vallourec: Andre Lacerda Appointed Senior Vice President of South America (Tubes Activities)
GlobeNewswire
7:30 AM
Transgene - First Patient Enrolled in Phase II Part of Randomized Phase I/II Trial Evaluating Lead C...
GlobeNewswire
05-29
AB Science provides an update on the application for conditional marketing authorisation of masitini...
GlobeNewswire
05-22
VEON Receives Nasdaq Notice on Delayed Filing, Confirms Ongoing Effort to Address Auditor Appointmen...
GlobeNewswire
05-03
Mithra enters into exclusive negotiations with Gedeon Richter and secures continued funding in the c...
GlobeNewswire
04-29
Mithra updates on offers received in the context of its monetization process and on its Annual Repor...
GlobeNewswire
04-25
GENFIT: Publication of the 2024 Extra-Financial Performance Report (fiscal year 2023)
GlobeNewswire
03-29
AERKOMM and Nasdaq-Listed IX Acquisition Corp. Announce Merger Agreement and US $35 Million Private ...
GlobeNewswire
03-25
ONWARD® Medical Publishes Closing of Accelerated Bookbuild Offering and Public Offering in France
GlobeNewswire
03-21
ONWARD® Medical Successfully Raises €20 Million in a Capital Increase by Way of an Accelerated Bookb...
GlobeNewswire
03-20
ONWARD® Medical Launches Capital Increase by Way of an Accelerated Bookbuild Offering and of a Publi...